Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Genenta Science S.p.A. (GNTA)

0.9850 +0.1560 (+18.82%)
At close: November 3 at 4:00:00 PM EST
Ticker Change
GNTA is trading under new symbol SAEN effective Nov. 4, 2026
Chart Range Bar
Loading chart for GNTA
  • Previous Close 0.8290
  • Open 0.8359
  • Bid 1.5300 x 500
  • Ask 0.7724 x 100
  • Day's Range 0.8189 - 0.9900
  • 52 Week Range 0.5500 - 2.5800
  • Volume 249,270
  • Avg. Volume 84,787
  • Market Cap (intraday) 47.494M
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3700
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

www.genenta.com

9

Full Time Employees

December 31

Fiscal Year Ends

Industrials

Sector

Conglomerates

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

GNTA
0.00%
MSCI WORLD (^990100-USD-STRD)
6.99%

1-Year Return

GNTA
0.00%
MSCI WORLD (^990100-USD-STRD)
9.59%

3-Year Return

GNTA
0.00%
MSCI WORLD (^990100-USD-STRD)
64.16%

5-Year Return

GNTA
0.00%
MSCI WORLD (^990100-USD-STRD)
0.00%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY22
Revenue --
Earnings --
Profit Margin 0.00%

Q2

FY22

0
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -17.67%

  • Return on Equity (ttm)

    -38.03%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -6.53M

  • Diluted EPS (ttm)

    -0.3700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.15M

  • Total Debt/Equity (mrq)

    34.81%

  • Levered Free Cash Flow (ttm)

    -3.1M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: